These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 23652276)

  • 1. Generation of antitumor peptides by connection of matrix metalloproteinase-9 peptide inhibitor to an endostatin fragment.
    Qiu Z; Hu J; Xu H; Wang W; Nie C; Wang X
    Anticancer Drugs; 2013 Aug; 24(7):677-89. PubMed ID: 23652276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemically synthesized matrix metalloproteinase and angiogenesis-inhibiting peptides as anticancer agents.
    Hu J; Yan M; Pu C; Wang J; Van den Steen PE; Opdenakker G; Xu H
    Anticancer Agents Med Chem; 2014 Mar; 14(3):483-94. PubMed ID: 24533654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RGD-modified endostatin fragments showed an antitumor effect through antiangiogenesis.
    Pu CY; Xu HM; Hu JL; Zheng H; Huang XF; Zhang C; Yang YJ; Li YB
    Anticancer Drugs; 2012 Sep; 23(8):788-802. PubMed ID: 22555196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of RGD-4C position is more important than disulfide bonds on antiangiogenic activity of RGD-4C modified endostatin derived synthetic polypeptide.
    Yin R; Zheng H; Xi T; Xu HM
    Bioconjug Chem; 2010 Jul; 21(7):1142-7. PubMed ID: 20515045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant snake venom metalloproteinase inhibitor BJ46A inhibits invasion and metastasis of B16F10 and MHCC97H cells through reductions of matrix metalloproteinases 2 and 9 activities.
    Ji MK; Shi Y; Xu JW; Lin X; Lin JY
    Anticancer Drugs; 2013 Jun; 24(5):461-72. PubMed ID: 23442578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antiangiogenic and antitumor activities of the N-terminal fragment of endostatin augmented by Ile/Arg substitution: The overall structure implicated the biological activity.
    Chamani R; Asghari SM; Alizadeh AM; Mansouri K; Doroudi T; Kolivand PH; Ghafouri H; Ehtesham S; Rabouti H; Mehrnejad F
    Biochim Biophys Acta; 2016 Dec; 1864(12):1765-1774. PubMed ID: 27693049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A fusion antitumor peptide regulates proliferation and apoptosis of endothelial cells.
    Xu Y; Qiang X; Xing L; Wang H; Zhang J; Zhang F; Caliskan B; Wang M; Qiu Z
    Amino Acids; 2018 Aug; 50(8):1121-1129. PubMed ID: 29796930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity.
    Nuti E; Cantelmo AR; Gallo C; Bruno A; Bassani B; Camodeca C; Tuccinardi T; Vera L; Orlandini E; Nencetti S; Stura EA; Martinelli A; Dive V; Albini A; Rossello A
    J Med Chem; 2015 Sep; 58(18):7224-40. PubMed ID: 26263024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endostatin inhibits human tongue carcinoma cell invasion and intravasation and blocks the activation of matrix metalloprotease-2, -9, and -13.
    Nyberg P; Heikkilä P; Sorsa T; Luostarinen J; Heljasvaara R; Stenman UH; Pihlajaniemi T; Salo T
    J Biol Chem; 2003 Jun; 278(25):22404-11. PubMed ID: 12690120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The COOH-terminal peptide of platelet factor-4 variant (CXCL4L1/PF-4var47-70) strongly inhibits angiogenesis and suppresses B16 melanoma growth in vivo.
    Vandercappellen J; Liekens S; Bronckaers A; Noppen S; Ronsse I; Dillen C; Belleri M; Mitola S; Proost P; Presta M; Struyf S; Van Damme J
    Mol Cancer Res; 2010 Mar; 8(3):322-34. PubMed ID: 20215425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of novel benzofuroxan-based pyrrolidine hydroxamates as matrix metalloproteinase inhibitors with nitric oxide releasing activity.
    Zhang H; Wang X; Mao J; Huang Y; Xu W; Duan Y; Zhang J
    Bioorg Med Chem; 2018 Aug; 26(15):4363-4374. PubMed ID: 30093347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pentanoic acid derivative targeting matrix metalloproteinase-2 (MMP-2) induces apoptosis in a chronic myeloid leukemia cell line.
    Mukherjee A; Adhikari N; Jha T
    Eur J Med Chem; 2017 Dec; 141():37-50. PubMed ID: 29028530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.
    Adhikari N; Halder AK; Mallick S; Saha A; Saha KD; Jha T
    Bioorg Med Chem; 2016 Sep; 24(18):4291-4309. PubMed ID: 27452283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-Activity Relationships of UTX-121 Derivatives for the Development of Novel Matrix Metalloproteinase-2/9 Inhibitors.
    Yamahana H; Komiya Y; Takino T; Endo Y; Yamada H; Asada C; Uto Y
    Chem Pharm Bull (Tokyo); 2021; 69(10):1017-1028. PubMed ID: 34602570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of endostatin and doxycycline on microcirculation patterns in melanoma and their relevant molecular mechanisms].
    Sun BC; Zhang SW; Qi LS; Zhang DF; Guo H; Zhao XL
    Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):500-4. PubMed ID: 18069628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-Regulated Expression of Matrix Metalloproteinases in Endothelial Cells Mediates Platelet Microvesicle-Induced Angiogenesis.
    Sun C; Feng SB; Cao ZW; Bei JJ; Chen Q; Zhao WB; Xu XJ; Zhou Z; Yu ZP; Hu HY
    Cell Physiol Biochem; 2017; 41(6):2319-2332. PubMed ID: 28463834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Battle tactics against MMP-9; discovery of novel non-hydroxamate MMP-9 inhibitors endowed with PI3K/AKT signaling attenuation and caspase 3/7 activation via Ugi bis-amide synthesis.
    Ayoup MS; Fouad MA; Abdel-Hamid H; Ramadan ES; Abu-Serie MM; Noby A; Teleb M
    Eur J Med Chem; 2020 Jan; 186():111875. PubMed ID: 31740054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the structure-activity relationship of endostatin: synthesis of human endostatin peptides exhibiting potent antiangiogenic activities.
    Chillemi F; Francescato P; Ragg E; Cattaneo MG; Pola S; Vicentini L
    J Med Chem; 2003 Sep; 46(19):4165-72. PubMed ID: 12954068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin-AE: a novel angiostatin-endostatin fusion protein with enhanced antiangiogenic and antitumor activity.
    Scappaticci FA; Contreras A; Smith R; Bonhoure L; Lum B; Cao Y; Engleman EG; Nolan GP
    Angiogenesis; 2001; 4(4):263-8. PubMed ID: 12197471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineered s-Triazine-Based Dendrimer-Honokiol Conjugates as Targeted MMP-2/9 Inhibitors for Halting Hepatocellular Carcinoma.
    Khalil HH; Osman HA; Teleb M; Darwish AI; Abu-Serie MM; Khattab SN; Haiba NS
    ChemMedChem; 2021 Dec; 16(24):3701-3719. PubMed ID: 34547831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.